Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease

被引:0
|
作者
Paniz Vafaei
Sahar Naderi
Andrew P. Ambrosy
Justin J. Slade
机构
[1] Kaiser Permanente San Francisco Medical Center,Department of Cardiology
[2] Kaiser Permanente Northern California,Division of Research
来源
Current Atherosclerosis Reports | 2021年 / 23卷
关键词
Stable ischemic heart disease; Coronary artery disease; Optimal medical therapy; Percutaneous coronary intervention;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease
    Vafaei, Paniz
    Naderi, Sahar
    Ambrosy, Andrew P.
    Slade, Justin J.
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (11)
  • [2] Beyond the ISCHEMIA Trial: Revascularization for Stable Ischemic Heart Disease in Patients With High-Risk Coronary Anatomical Features
    Bergmark, Brian A.
    Morrow, David A.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (01): : 1 - 4
  • [3] Lessons Learned from the ISCHEMIA Trial for the Management of Patients with Stable Ischemic Heart Disease
    Boden, William E.
    Stone, Peter H.
    ANNUAL REVIEW OF MEDICINE, 2023, 74 : 189 - 198
  • [4] Contemporary Management of Patients with Stable Ischemic Heart Disease
    Lyubarova, Radmila
    Schulman-Marcus, Joshua
    Boden, William E.
    CARDIOVASCULAR INNOVATIONS AND APPLICATIONS, 2019, 3 (03) : 269 - 278
  • [5] Initial Invasive Versus Conservative Management of Stable Ischemic Heart Disease in Patients With a History of Heart Failure or Left Ventricular Dysfunction Insights From the ISCHEMIA Trial
    Lopes, Renato D.
    Alexander, Karen P.
    Stevens, Susanna R.
    Reynolds, Harmony R.
    Stone, Gregg W.
    Pina, Ileana L.
    Rockhold, Frank W.
    Elghamaz, Ahmed
    Lopez-Sendon, Jose Luis
    Farsky, Pedro S.
    Chernyavskiy, Alexander M.
    Diaz, Ariel
    Phaneuf, Denis
    De Belder, Mark A.
    Ma, Yi-tong
    Guzman, Luis A.
    Khouri, Michel
    Sionis, Alessandro
    Hausenloy, Derek J.
    Doerr, Rolf
    Selvanayagam, Joseph B.
    Maggioni, Aldo Pietro
    Hochman, Judith S.
    Maron, David J.
    CIRCULATION, 2020, 142 (18) : 1725 - 1735
  • [6] Percutaneous coronary intervention for the management of stable ischemic heart disease
    Liu, Shuangbo
    Tsang, Michael
    Abdel-Qadir, Husam
    Yanagawa, Bobby
    Bagai, Akshay
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (05) : 557 - 563
  • [7] The role of ISCHEMIA in stable ischemic heart disease
    Spilias, Nikolaos
    Zorach, Benjamin
    Denby, Kara
    Ellis, Stephen
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (07) : 401 - 409
  • [8] Contemporary Management of Stable Coronary Artery Disease - Implications of the ISCHEMIA Trial -
    Kohsaka, Shun
    Fukushima, Kenji
    Watanabe, Ippei
    Manabe, Susumu
    Niimi, Nozomi
    Gatate, Yodo
    Sawano, Mitsuaki
    Nakano, Shintaro
    CIRCULATION JOURNAL, 2021, 85 (11) : 1919 - +
  • [9] Conservative versus invasive stable ischemic heart disease management strategies: what do we plan to learn from the ISCHEMIA trial?
    Cheng-Torres, Kathleen A.
    Desai, Karan P.
    Sidhu, Mandeep S.
    Maron, David J.
    Boden, William E.
    FUTURE CARDIOLOGY, 2016, 12 (01) : 35 - 44
  • [10] Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease
    Bainey, Kevin R.
    Alemayehu, Wendimagegn
    Welsh, Robert C.
    Kumar, Arnav
    King, Spencer B., III
    Kirtane, Ajay J.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (01): : 1 - 12